Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
about
Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel diseaseThe Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure?Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.The Microbiota and Epigenetic Regulation of T Helper 17/Regulatory T Cells: In Search of a Balanced Immune SystemThe Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.Management of inflammatory bowel disease with Clostridium difficile infection.Microbiome and metabolome data integration provides insight into health and disease.The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.The microbiome: current and future view of an ancient paradigm.New treatment strategies for ulcerative colitis.Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals.Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases.From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases.Gut microbiota and IBD: causation or correlation?Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial.Microbiomarkers in inflammatory bowel diseases: caveats come with caviar.Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity.Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?Environmental triggers in IBD: a review of progress and evidence.A role for bacterial urease in gut dysbiosis and Crohn's disease.The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation.Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series.Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease.Gut microbiota in the pathogenesis of inflammatory bowel disease.Interactions between diet and the intestinal microbiota alter intestinal permeability and colitis severity in mice.Faecal transplantation for IBD management-pitfalls and promises.Recipe for IBD: can we use food to control inflammatory bowel disease?Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire?Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet?Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet? Authors' reply.Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.IBD in 2017: Development of therapy for and prediction of IBD - getting personal.Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.Correlation, consequence, and functionality in microbiome-immune interplay.
P2860
Q33691783-5E6E6173-181A-4511-A3AC-CB5EE5D88A66Q33810037-65A69A49-6D0A-4126-8FFA-A7A72F551466Q36404998-202B87AD-21E7-45EA-8921-F4CFD4007F51Q37742909-16FF20DD-EB19-4C9A-BAE0-DD617B79A2A4Q38600245-37A5792E-58CD-42CA-96A6-BFCADD0B8398Q38635974-FE378DAE-0976-463F-9732-BF797CF35F1BQ38648247-F2EFF872-ADFA-4D08-ACAD-3F8F5F0D18E2Q38658559-1D9036FD-9AF6-4050-9873-7FAB0A0CFA5FQ38665286-2BA0DDF3-F758-4173-932B-E5B171B037FBQ38670811-6A7A60D0-C017-43BD-88ED-F03C95479DA1Q38765317-8B87C0C7-1CA1-4150-9BFF-84DE736B767AQ38795652-41C762EE-193F-4F63-9BAE-074510D8CC54Q39336917-29749783-DD8B-4393-80F3-E5D6DE4DBE70Q39376100-309E2B39-44B3-435D-8E59-70AD34DE4617Q39458190-3BB9C310-2C38-4A04-9194-06B04B788A0BQ40085244-E042BF87-E3F3-4727-A7A7-BFD141EFC806Q40124428-B1856126-3662-4D2D-918A-F78A4CD37636Q40227125-71E99D52-9EE2-4DCD-B038-404924D8596CQ40234279-75765B41-7AFE-47A1-ADB6-AC829E5461C9Q41127262-763F393A-6416-4E71-8249-FD93BA739D22Q41996759-082F0010-1C19-42A8-9212-E8EBD95A1111Q42351259-16D06D5A-70E1-43F9-B76A-250DE2843832Q46026239-2F4A83C7-6ED8-4D32-8D45-E9522A1DF511Q46260829-FE2A24ED-EE28-41E3-A62B-CA190302BF3BQ46279754-AA29D693-04F7-4E80-88EB-6E4AD99D9351Q46284784-A7026D61-90B7-43B4-8D3B-11B13B8F4216Q46386059-EE574356-2CD7-48D7-ADF3-AE9E1DFA71CAQ47112915-33A8D4FF-BE74-4FB9-B3C3-FDCA88A7227EQ47180359-F46688D1-DFFF-47ED-87EC-9BD4C61A0666Q47236027-CC9EB1C5-E52E-4D4B-8E79-72B863B9AC45Q47365730-AA863782-7546-4EDB-8574-904FD566E41AQ47593592-08228DED-7D33-4313-8D02-61D80942C62AQ47620230-84F984B8-BBEC-4842-BB04-ED52C28C390FQ47686862-A6DC96E1-29A2-45E4-BF1B-7797C4035963Q48245659-BC3881EE-5372-4275-A7CC-64D8FCC105C9Q48245665-595DA9D0-B596-4941-954B-E9C67CACDD09Q49733575-A7EFA0E9-ACCE-4803-A523-AAE6AA12D8ADQ50057718-2D268EE9-1773-47F2-ACCE-56C21CA67722Q50106347-2878F877-8E0B-4BCD-BDC7-C90D052EDD17Q50253775-2B725186-1C35-4EA4-86E5-6B6C0C0EAC7D
P2860
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Multidonor intensive faecal mi ...... ised placebo-controlled trial.
@en
type
label
Multidonor intensive faecal mi ...... ised placebo-controlled trial.
@en
prefLabel
Multidonor intensive faecal mi ...... ised placebo-controlled trial.
@en
P2093
P50
P1433
P1476
Multidonor intensive faecal mi ...... mised placebo-controlled trial
@en
P2093
Alissa J Walsh
Douglas Samuel
Hazel M Mitchell
Johan van den Bogaerde
Michael A Kamm
Ramesh Paramsothy
Rupert W L Leong
Sudarshan Paramsothy
Susan Connor
P304
P356
10.1016/S0140-6736(17)30182-4
P407
P577
2017-02-15T00:00:00Z